Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adenovirus-Based Vaccines for Fighting Infectious Diseases and Cancer: Progress in the Field
Dragomira Majhen, Hugo Calderón, Naresh Chandra, et al.
Human Gene Therapy (2014) Vol. 25, Iss. 4, pp. 301-317
Closed Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Vaccine Adjuvants: from 1920 to 2015 and Beyond
Alberta Di Pasquale, Scott Preiss, Fernanda Tavares Da Silva, et al.
Vaccines (2015) Vol. 3, Iss. 2, pp. 320-343
Open Access | Times Cited: 592
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Jian Liu, Minyang Fu, Manni Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 469
Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers
Tuuli Ranki, Sari Pesonen, Akseli Hemminki, et al.
Journal for ImmunoTherapy of Cancer (2016) Vol. 4, Iss. 1
Open Access | Times Cited: 183
Recent advances of oncolytic virus in cancer therapy
Moumita Mondal, Jingao Guo, Ping He, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 10, pp. 2389-2402
Open Access | Times Cited: 164
An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
Cielo García‐Montero, Oscar Fraile‐Martínez, Coral Bravo, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 433-433
Open Access | Times Cited: 105
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 432-432
Open Access | Times Cited: 51
Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy
Popat Mohite, Vaishnavi Yadav, Ramdas Pandhare, et al.
ACS Omega (2024)
Open Access | Times Cited: 17
Improved virus purification processes for vaccines and gene therapy
Piergiuseppe Nestola, Cristina Peixoto, Ricardo J. S. Silva, et al.
Biotechnology and Bioengineering (2015) Vol. 112, Iss. 5, pp. 843-857
Closed Access | Times Cited: 118
Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls
Mohan Babu Appaiahgari, Sudhanshu Vrati
Expert Opinion on Biological Therapy (2014) Vol. 15, Iss. 3, pp. 337-351
Closed Access | Times Cited: 104
Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects
Julien Baruteau, Simon N. Waddington, Ian E. Alexander, et al.
Journal of Inherited Metabolic Disease (2017) Vol. 40, Iss. 4, pp. 497-517
Open Access | Times Cited: 100
Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens
Sam Afkhami, Yushi Yao, Zhou Xing
Molecular Therapy — Methods & Clinical Development (2016) Vol. 3, pp. 16030-16030
Open Access | Times Cited: 97
Adenovirus Vectors: Excellent Tools for Vaccine Development
Jun Chang
Immune Network (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 96
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Benoît Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
PLoS ONE (2018) Vol. 13, Iss. 2, pp. e0192312-e0192312
Open Access | Times Cited: 88
Human adenovirus type 26 uses sialic acid–bearing glycans as a primary cell entry receptor
Alexander T. Baker, Rosie M. Mundy, James A. Davies, et al.
Science Advances (2019) Vol. 5, Iss. 9
Open Access | Times Cited: 82
Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
Yaqi Zhao, Zheming Liu, Lan Li, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 67
Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects
Madhu Gupta, Abhishek Wahi, Priyanka Sharma, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2011-2011
Open Access | Times Cited: 47
Enzyme/Prodrug Systems for Cancer Gene Therapy
Obeid M. Malekshah, Xuguang Chen, Alireza Nomani, et al.
Current Pharmacology Reports (2016) Vol. 2, Iss. 6, pp. 299-308
Open Access | Times Cited: 84
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy
Daniel H. Sterman, Evan Alley, James Stevenson, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 15, pp. 3791-3800
Open Access | Times Cited: 83
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
Hanni Uusi-Kerttula, Sarah L. Hulin-Curtis, James A. Davies, et al.
Viruses (2015) Vol. 7, Iss. 11, pp. 6009-6042
Open Access | Times Cited: 81
Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations
Ignazio Maggio, Luca Stefanucci, Josephine M. Janssen, et al.
Nucleic Acids Research (2016) Vol. 44, Iss. 3, pp. 1449-1470
Open Access | Times Cited: 74
Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications
Ishita Gupta, Ola Hussein, Konduru S. Sastry, et al.
Advances in Cancer Biology - Metastasis (2023) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 19
Clinical Application of Adenovirus (AdV): A Comprehensive Review
Md. Salauddin, Sukumar Saha, Md. Golzar Hossain, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1094-1094
Open Access | Times Cited: 6
Vector-based genetically modified vaccines: Exploiting Jenner’s legacy
Bahar Ramezanpour, Ingrid Haan, Ab Osterhaus, et al.
Vaccine (2016) Vol. 34, Iss. 50, pp. 6436-6448
Open Access | Times Cited: 57
A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection
Jin Huk Choi, Kristina Jonsson‐Schmunk, Xiangguo Qiu, et al.
Molecular Pharmaceutics (2014) Vol. 12, Iss. 8, pp. 2712-2731
Open Access | Times Cited: 54
Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy
Julia Niemann, Norman Woller, Jennifer D. Brooks, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 54
Page 1 - Next Page

Scroll to top